To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.

Fact Sheet API

Bill Number

HR 5587

Introduced

Jan 13, 2020

Latest Action

Referred to the Subcommittee on Biotechnology, Horticulture, and Research.

Sponsor

Cosponsors

Topics

Administrative law and regulatory procedures Congressional oversight Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Drug, alcohol, tobacco use Food supply, safety, and labeling Government studies and investigations Health State and local government operations

Full Text

View Full Bill Text

Votes

Summary

This bill requires the Food and Drug Administration to regulate a hemp-derived cannabidiol (CBD) product as a dietary supplement instead of as a drug. The bill also allows the introduction into interstate commerce of a food with added hemp-derived CBD.

The Department of Agriculture must report on market and regulatory barriers for producers operating under its domestic hemp production program.

Actions

Jan 23, 2020

Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
Jan 13, 2020

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 13, 2020

Introduced in House

Amendments

Related Bills